SCI Pharmtech reports Sep revenue of NT$163.4M
SCI Pharmtech Inc. reported September revenue of NT$163,394,000 versus NT$122,806,000 a year earlier, with Jan-Sep revenue at NT$1,151,808,000 versus NT$988,248,000.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.